Haleos Labs Schedules Board Meeting to Consider Q2 Results
Haleos Labs Ltd 路 Intimation 路 11 Nov 2026, 5:30 am
Haleos Labs Schedules Board Meeting to Consider Q2 Results Haleos Labs Limited has scheduled its 99th Board of Directors meeting for 11th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives until 13th Nov'26 under SEBI Prohibition of Insider Trading Regulations.
Original exchange filing (PDF)
More announcements from Haleos Labs Ltd
- Enclosed - Newspaper advertisement for Q2F27 (results) 路 12 Nov 2026
- Enclosed - Outcome of 99th Board meeting. 路 11 Nov 2026
- HALEOS LABS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 11 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 11 Nov 2026
- Haleos Labs Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 11 Nov 2026
- Dividend payable to shareholders who have not yet updated their KYC details is withheld and shall be released upon compliance with the KYC norms. 路 31 Oct 2026
- Enclosed 路 02 Oct 2026
- Enclosed 路 01 Oct 2026
